home.social

#zacksinvestmentresearch — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #zacksinvestmentresearch, aggregated by home.social.

fetched live
  1. GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?

    GSK GSK and Sanofi SNY are two major European drugmakers with diversified portfolios spanning vaccines, specialty medicines and…
    #EuropeSays #Britain #Europe #EU #GSK #GSKstock #HIVmedicines #salesgrowth #SanofiStock #ZacksInvestmentResearch
    europesays.com/britain/148962/

  2. NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk

    Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #cardiovasculardeath #cardiovascularevents #COMPETESWITCHCardiovascular #Health #Mounjaro #novo #Ozempicdose #patients #T2D #ZacksInvestmentResearch
    newsbeep.com/us/866815/

  3. NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk

    Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
    #NewsBeep #News #Medication #AU #Australia #cardiovasculardeath #cardiovascularevents #COMPETESWITCHCardiovascular #Health #Mounjaro #novo #Ozempicdose #patients #T2D #ZacksInvestmentResearch
    newsbeep.com/au/911625/

  4. NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk

    Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
    #NewsBeep #News #Medication #cardiovasculardeath #cardiovascularevents #COMPETESWITCHCardiovascular #Health #Mounjaro #novo #Ozempicdose #Patients #T2D #UK #UnitedKingdom #ZacksInvestmentResearch
    newsbeep.com/uk/787976/

  5. Realty Income Expands in Europe: Can the Region Drive More Growth?

    Realty Income’s O recent European move is less about buying property and more about changing how it funds…
    #Europe #EU #GlobalNetLease #RealtyIncome #ZacksInvestmentResearch
    europesays.com/europe/149661/

  6. GSK vs. SNY: Which Europe-Based Pharma Stock Has More Potential?

    GSK GSK and Sanofi SNY are two major European drugmakers with diversified portfolios spanning vaccines, specialty medicines and…
    #Europe #EU #GSKStock #HIVmedicines #salesgrowth #SanofiStock #ZacksInvestmentResearch
    europesays.com/europe/148899/

  7. Delta Expands Europe Network With New Routes From Detroit and Boston

    Delta Air Lines DAL expanded its European network, giving travelers more nonstop options and greater flexibility. The new…
    #Europe #EU #DeltaAirLines #Detroit #EarningsGrowth #ZacksInvestmentResearch
    europesays.com/europe/148858/

  8. Volkswagen Taps Gotion to Expand Europe’s LFP Battery Supply Chain

    Volkswagen AG VWAGY is strengthening its position in the European electric vehicle (EV) battery market through a partnership…
    #Europe #EU #batterymarket #cathodematerials #consensusestimate #Gotion #LFP) #PowerCo #Volkswagen #ZacksInvestmentResearch
    europesays.com/europe/148684/

  9. Volkswagen Taps Gotion to Expand Europe’s LFP Battery Supply Chain

    Volkswagen AG VWAGY is strengthening its position in the European electric vehicle (EV) battery market through a partnership…
    #Germany #DE #Europe #EU #Europa #Volkswagen #batterymarket #cathodematerials #ConsensusEstimate #Gotion #LFP #PowerCo #ZacksInvestmentResearch
    europesays.com/germany/100248/

  10. Is AstraZeneca’s Oncology Portfolio Positioned for Continued Growth?

    Over the past decade, AstraZeneca AZN has built a broad oncology franchise spanning multiple cancer types, including lung,…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #advancedbreastcancer #breAstcancer #Prostatecancer #revenues #ZacksInvestmentResearch
    europesays.com/britain/133177/

  11. VWAGY Flags Major Charges as Porsche and China Pressure Hits Profit

    Volkswagen AG VWAGY has issued a profit warning, flagging around €10 billion ($11.5 billion) in one-time charges for…
    #Germany #DE #Europe #EU #Europa #Porsche #China #ReturnonSales #Volkswagen #ZacksInvestmentResearch
    europesays.com/germany/99132/

  12. Sanofi’s New Drugs Poised to Drive Growth Beyond Dupixent

    Sanofi’s SNY most important medicine remains its immunology drug, Dupixent, which continues to be the company’s primary growth…
    #France #FR #Europe #EU #Sanofi #Dupixent #globalsales #SanofimarketsDupixent #ZacksInvestmentResearch
    europesays.com/france/85007/

  13. HSBC Targets Higher-Return Growth: Can the Stock Keep Climbing?

    HSBC Holdings HSBC is sharpening its growth strategy around businesses where it already has scale and competitive advantages,…
    #EuropeSays #Britain #Europe #EU #HSBC #growthstrategy #hangsengbank #ZacksInvestmentResearch
    europesays.com/britain/131858/

  14. Sanofi’s New Drugs Poised to Drive Growth Beyond Dupixent

    Sanofi’s SNY most important medicine remains its immunology drug, Dupixent, which continues to be the company’s primary growth…
    #France #FR #Europe #EU #Sanofi #Dupixent #globalsales #SanofimarketsDupixent #ZacksInvestmentResearch
    europesays.com/france/84420/

  15. NIKE vs. adidas: Which Athletic Giant Has the Stronger Market Position?

    In the global athletic footwear and apparel market, few rivalries are as entrenched as the battle between NIKE,…
    #Germany #DE #Europe #EU #Europa #Adidas #adidasAG #consumerdemand #Marketplace #nike #Performance #ZacksInvestmentResearch
    europesays.com/germany/97265/

  16. AstraZeneca’s Trixeo Secures Approval for Asthma in the EU

    AstraZeneca AZN announced that the European Commission has approved its respiratory drug, Trixeo Aerosphere, for a new indication.…
    #Europe #EU #EuropeanCommission #asthma #EuropeanMedicinesAgency #EuropeanUnion #LABA #respiratorydrug #treatmentofCOPD #TrixeoAerosphere #ZacksInvestmentResearch #ZacksRank
    europesays.com/europe/144951/

  17. Natera’s Signatera Wins Japan PMDA Approval as Bladder Cancer CDx

    Natera NTRA recently announced that its Signatera test received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency…
    #EuropeSays #Japan #JP #atezolizumab #bladdercancer #FDAapproval #MIBC #MRD #Natera #Nihon #PMDA #regulatoryapproval #ZacksInvestmentResearch
    europesays.com/japan/96025/

  18. United Airlines Adds First U.S.-Sapporo Nonstop, Boosts Japan Service

    United Airlines UAL is strengthening its position as the leading U.S. carrier in the Japan market with the addition of nonstop services to Sapporo and Tokyo-Nari…
    #Japan #JP #Hokkaido #HokkaidoNews #internationalroutes #news #premiuminternationaltravel #tokyonarita #ual #unitedairlines #ZacksInvestmentResearch #ZacksRank #北海道
    alojapan.com/1487771/united-ai

  19. alojapan.com/1487771/united-ai United Airlines Adds First U.S.-Sapporo Nonstop, Boosts Japan Service #Hokkaido #HokkaidoNews #InternationalRoutes #Japan #news #PremiumInternationalTravel #TokyoNarita #ual #UnitedAirlines #ZacksInvestmentResearch #ZacksRank #北海道 United Airlines UAL is strengthening its position as the leading U.S. carrier in the Japan market with the addition of nonstop services to Sapporo and Tokyo-Narita. The expansion reflects the airline’s continued foc

  20. “Long-term investors out there are responding to excessive share valuations in a number of sectors. When faced with possible disruptions from AI, the mentality has been to shoot first and ask questions later” #JohnBlank chief economist at #ZacksInvestmentResearch www.marketwatch.com/story/more-c...

    More companies than usual are ...

Share on Mastodon

Enter the server where you have an account.